Carlos Alberto Pastore | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Prof. Carlos Alberto Pastore | Medicine and Health Sciences | Best Researcher Award

Heart Institute of the Hospital das Clínicas of FMUSP | Brazil

Prof. Carlos Alberto Pastore is a distinguished cardiologist and researcher from the University of São Paulo, Brazil, internationally recognized for his pioneering work in electrocardiology and vectorcardiography. As a Professor and Medical Collaborator at the Faculty of Medicine, University of São Paulo (FMUSP), he has significantly advanced diagnostic methods for cardiac electrical diseases, cardiac mapping, and non-invasive electrocardiographic techniques. His research specializes in surface electrocardiographic mapping, high-resolution ECG, microalternans of the T wave (mTWA), and vectorcardiographic analysis of ventricular activation and repolarization abnormalities. Prof. Carlos Alberto Pastore has played a vital role in refining diagnostic criteria for arrhythmogenic disorders, ventricular hypertrophy, and cardiac resynchronization therapy, and he has applied artificial neural networks and machine learning in ECG-based cardiopathy detection in collaboration with the Federal University of Technology of Paraná (UTFPR). At InCor – Heart Institute (Hospital das Clínicas, FMUSP), he has held major roles including Director of the Clinical Unit of Resting Electrocardiography, Medical Director of Telemedicine, and Vice-President of the Zerbini Foundation, contributing to translational cardiology and digital health innovation. He also served as President (2013–2015) of the International Society of Electrocardiology (ISE) and is a Fellow of the European Society of Cardiology (FESC). According to Scopus (Author ID: 7006635654), Prof. Carlos Alberto Pastore has authored 53 scientific publications, received 1,014 citations from 948 documents, and holds an h-index of 12. His research has appeared in leading journals including the Journal of Electrocardiology, Annals of Noninvasive Electrocardiology, Arquivos Brasileiros de Cardiologia, and JACC, making him one of Brazil’s leading authorities in clinical electrocardiology and cardiovascular diagnostics.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate

Featured Publications

• de Luna, A. B., Brugada, J., Baranchuk, A., Borggrefe, M., Breithardt, G., & Pastore, C. A. (2012). Current electrocardiographic criteria for diagnosis of Brugada pattern: A consensus report. Journal of Electrocardiology, 45(5), 433–442.* https://doi.org/10.1016/j.jelectrocard.2012.06.004

• de Luna, A. B., Platonov, P., Cosio, F. G., Cygankiewicz, I., Pastore, C., Baranowski, R., … & Spodick, D. (2012). Interatrial blocks: A separate entity from left atrial enlargement: A consensus report. Journal of Electrocardiology, 45(5), 445–451.* https://doi.org/10.1016/j.jelectrocard.2012.06.008

• Pastore, C. A., Pinho, J. A., Pinho, C., Samesima, N., Pereira Filho, H. G., & Mansur, A. P., et al. (2016). III Diretrizes da Sociedade Brasileira de Cardiologia sobre análise e emissão de laudos eletrocardiográficos. Arquivos Brasileiros de Cardiologia, 106(4 Suppl 1), 1–23.* https://doi.org/10.5935/abc.20160054

• Santos, I. S., Goulart, A. C., Brandão, R. M., Santos, R. C. O., Bittencourt, M. S., Sitnik, D., … & Pastore, C. A. (2015). One-year mortality after an acute coronary event and its clinical predictors: The ERICO study. Arquivos Brasileiros de Cardiologia, 105(1), 53–64.* https://doi.org/10.5935/abc.20150049

• Digby, G. C., Kukla, P., Zhan, Z. Q., Pastore, C. A., Piotrowicz, R., Schapachnik, E., … & Baranchuk, A. (2015). The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: A consensus paper. Annals of Noninvasive Electrocardiology, 20(3), 207–223.* https://doi.org/10.1111/anec.12235

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Naila Camila da Rocha | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Naila Camila da Rocha | Medicine and Health Sciences | Best Researcher Award

University of Wisconsin-Madison | United States

Dr. Naila Camila da Rocha is a distinguished researcher specializing in biostatistics, artificial intelligence in healthcare, and predictive analytics, with a strong focus on advancing precision medicine and healthcare delivery. She is completing her Ph.D. in Biometrics at São Paulo State University (UNESP) in collaboration with the University of Wisconsin–Madison, following a Master’s in Biometrics, a Professional Master’s in Applied Statistics, and a Bachelor’s in Administration. With over 14 years of experience in strategic planning, business intelligence, and applied statistics, she has held leadership roles including Head of Growth Strategy and Revenue at iFood, Data Science Manager at BRF, and currently works as a Data Scientist at Statbit, while also contributing as a volunteer researcher at the Clinics Hospital of Botucatu (LabData). Her research applies machine learning, natural language processing, and advanced statistical modeling to nephrology, transplantation, and chronic disease management, with impactful results such as predictive models for graft rejection, delayed graft function, and inequities in hemodialysis access. She has published more than 20 peer-reviewed papers in high-impact journals and received multiple prestigious awards, including the Massola Award (2025), AACD Summit Award (2025), Magaldi Award (2023), and Nestor Schor Award (2023). By successfully bridging data science with clinical applications, she has established herself as an influential voice in developing innovative tools for early diagnosis, risk stratification, and health system optimization, demonstrating excellence as a researcher whose work is shaping both academic knowledge and practical healthcare solutions.

Profile: Google Scholar | ORCID

Featured Publications

  • Beltramino, L., Bedacarratx, V., Roldán, P., González, N. A. M., … (2020). Aprendizajes y prácticas educativas en las actuales condiciones de época: COVID-19. Universidad Nacional de Córdoba, Facultad de Filosofía y Humanidades. Cited by: 33

  • Da Rocha, N. C., Barbosa, A. M. P., Schnr, Y. O., Machado-Rugolo, J., … (2022). Natural language processing to extract information from Portuguese-language medical records. Data, 8(1), 11. Cited by: 13

  • De Andrade, L. G. M., Barbosa, A. M. P., Da Rocha, N. C., Cardoso, M. M. de A., … (2022). Impact of the COVID-19 pandemic on solid organ transplant and rejection episodes in Brazil’s Unified Healthcare System. Journal of Clinical Medicine, 11(21), 6581. Cited by: 11

  • Ordones, F. V., Kawano, P. R., Vermeulen, L., Hooshyari, A., Scholtz, D., … (2025). A novel machine learning-based predictive model of clinically significant prostate cancer and online risk calculator. Urology, 196, 20–26. Cited by: 5

  • Addad, V. V., Palma, L. M. P., Vaisbich, M. H., Barbosa, A. M. P., … (2023). A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: The TMA-INSIGHT score. Thrombosis Journal, 21(1), 119. Cited by: 5

  • Santos, G. P. A., Sesso, R., Lugon, J. R., Neves, P. D. M. de M., Barbosa, A. M. P., … (2024). Geographic inequities in hemodialysis access: A call to reassess dialysis facility locations in Brazil. Journal of Nephrology, 37(9), 2601–2608. Cited by: 4